is the fda banning bpc 157 An advisory panel voted on BPC-157 today., That does not mean BPC-157 was FDA approved., panel recommended that BPC-157 be considered for addition to a list of substances that may be used by An FDA Committee Just Voted

[PubMed] [Google Scholar] 78.Martinez-Botas J, Anderson JB, Tessier D, Lapillonne A, Chang BH, et al

The cagrilintide mechanism of action centers on mimicking the natural hormone amylin, which is normally co-secreted with insulin from pancreatic beta cells

In published preclinical research, BPC-157 has been administered at doses ranging from 6 to 50 micrograms per kilogram body weight in animal models, with most tissue-repair and gastric-protection protocols using 10 to 20 mcg/kg once or twice daily (PMID 21030672, PMID 32558293, PMID 38980576)

So when I look at something like saying no to this and pushing it to the gray market, am I doing greater harm

If you have used tirzepatide or semaglutide before and experienced moderate nausea, starting retatrutide at the standard 1mg and capping at 8mg often provides the best balance between efficacy and quality of life

Using degraded medication reduces effectiveness and can cause irritation